Safety and Efficacy of Sufentanil Administration by Paramedics in Acute Trauma
Safety and Efficacy of Sufentanil Administration by Paramedics in Acute Trauma in Prehospital Setting: Observational Study
Zdravotnicka Zachranna Sluzba Karlovarskeho Kraje, P.O.
300 participants
Jul 1, 2024
OBSERVATIONAL
Conditions
Summary
The safety and efficacy of competence of paramedics to administer sufentanil intravenously in adult acute trauma patients without presence or without phone-call consult with an emergency medical doctor will be assessed in this observational study. Condition or disease: pain in trauma or injury. Intervention/treatment: sufentanil administered by paramedics after the phone call consultation of medical doctor versus sufentanil administered by paramedics based on their competency, without consultation of medical doctor.
Eligibility
Inclusion Criteria4
- acute trauma with severe pain (VAS/NRS > 4)
- age > 18 years
- conscious patient (GCS = 15; alert in AVPU)
- haemodynamically stable patient (> 100mmHg of systolic blood pressure, > 60/min of heart rate)
Exclusion Criteria5
- EMS doctor on site
- paediatric patient (less than 18 years)
- predominantly chronic but not acute pain
- incomplete documentation
- other than traumatic reasons for opioid administration (eg. acute coronary syndrome)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intravenous administration of sufentanil to patients with acute injury by paramedics only after phone-call consultation of medical doctor.
Intravenous administration of sufentanil to patients with acute injury by paramedics based on their competencies
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06514469